Cargando…
Highlights in heart failure
Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is an area of active research. This article is aimed to give an update on recent advances in all aspects of this syndrome. Major changes occurred in drug treatment of HF with reduced ejection fraction (HFr...
Autores principales: | Tomasoni, Daniela, Adamo, Marianna, Lombardi, Carlo Mario, Metra, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989277/ https://www.ncbi.nlm.nih.gov/pubmed/31997538 http://dx.doi.org/10.1002/ehf2.12555 |
Ejemplares similares
-
Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
por: Tomasoni, Daniela, et al.
Publicado: (2022) -
Inflammation in acute heart failure
por: Garofalo, Manuel, et al.
Publicado: (2023) -
Heart failure in the last year: progress and perspective
por: Tomasoni, Daniela, et al.
Publicado: (2020) -
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction
por: Riccardi, Mauro, et al.
Publicado: (2022) -
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
por: Italia, Leonardo, et al.
Publicado: (2021)